Average Co-Inventor Count = 11.40
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bayer Pharma Aktiengesellschaft (26 from 378 patents)
2. The Broad Institute, Inc. (12 from 443 patents)
3. Bayer Intellectual Property Gmbh (11 from 721 patents)
4. Bayer Aktiengesellschaft (9 from 12,160 patents)
5. Harvard College (6 from 2,963 patents)
6. The General Hospital Corporation (6 from 2,893 patents)
7. Dana-farber-cancer Institute Inc. (4 from 1,209 patents)
8. Bayer Schering Pharma Ag (4 from 192 patents)
9. Schering Aktiengesellschaft (1 from 1,384 patents)
10. Bayer Aktiengellschaft (1 from 5 patents)
11. Bayer Pharma Aktiengellschaft (1 from 1 patent)
12. Bayer Pharma Aktiegellschaft (1 from 1 patent)
41 patents:
1. 12486248 - 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH
2. 12053476 - Compounds, compositions and methods for cancer patient stratification and cancer treatment
3. 11787797 - 4,5-annulated 1,2,4-triazolones
4. 11713304 - 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH
5. 11529356 - 2-(morpholin-4-yl)-1,7-naphthyridines
6. 11492358 - Macrocyclic indole derivatives
7. 11339157 - 4H-pyrrolo[3,2-c]pyridin-4-one derivatives
8. 11142522 - Compounds, compositions and methods for cancer treatment
9. 11130745 - 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH
10. 10981932 - Macrocyclic indole derivatives
11. 10968216 - 4,5-annulated 1,2,4-triazolones
12. 10966986 - Compounds, compositions and methods for cancer patient stratification and cancer treatment
13. 10894784 - Heteroarylbenzimidazole compounds
14. 10815215 - 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH
15. 10772893 - 2-(morpholin-4-yl)-1,7-naphthyridines